SOURCE: Virginia Tech, news release, Jan
The study evaluated multiple dose levels over a 48-week period and reported dose-dependent reductions in body weight alongside improvements in several cardiometabolic biomarkers
Murthy SK, Malhotra AK, Mani S, Maryam EA, Shara EE, Al-Rowaished M, Naveed S, Alkhayat AI, Alali MT (2007) Incidence of Down Syndrome in Dubai, UAE
Target(s) : Na+/Glucose Cotransporter 2 in kidney
Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor-binding protein-1 through proximal promoter elements
Under these conditions, metabolism shifts toward increased reliance on lipid-derived substrates and elevated oxidative throughput